CALCIUM-CHANNEL BLOCKERS AS INHIBITORS OF DRUG-METABOLISM

被引：18

作者：

HUNT, BA

SELF, TH

LALONDE, RL

BOTTORFF, MB

机构：

来源：

CHEST | 1989年 / 96卷 / 02期

关键词：

D O I：

10.1378/chest.96.2.393

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：393 / 399

页数：7

共 50 条

[1]

ABERNETHY DR, 1986, CLIN RES, V34, pA394

[2] THE EFFECT OF VERAPAMIL ON ANTIPYRINE PHARMACOKINETICS AND METABOLISM IN MAN [J].

BACH, D ;

BLEVINS, R ;

KERNER, N ;

RUBENFIRE, M ;

EDWARDS, DJ .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 (06) :655-659

[3] CHANGES IN ANTIPYRINE AND INDOCYANINE GREEN KINETICS DURING NIFEDIPINE, VERAPAMIL, AND DILTIAZEM THERAPY [J].

BAUER, LA ;

STENWALL, M ;

HORN, JR ;

DAVIS, R ;

OPHEIM, K ;

GREENE, L .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (02) :239-242

[4]

BOTTORFF MB, 1988, PHARMACOTHERAPY, V8, P126

[5]

BOURBIGOT B, 1986, LANCET, V1, P1447

[6] CARBAMAZEPINE NEUROTOXICITY PRECIPITATED BY DILTIAZEM [J].

BRODIE, MJ ;

MACPHEE, GJA .

BRITISH MEDICAL JOURNAL, 1986, 292 (6529) :1170-1171

[7]

BURNAKIS TG, 1983, CLIN PHARMACY, V2, P458

[8] DILTIAZEM TREATMENT IMPAIRS HEPATIC DRUG OXIDATION - STUDIES OF ANTIPYRINE [J].

CARRUM, G ;

EGAN, JM ;

ABERNETHY, DR .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (02) :140-143

[9]

DEVITO JM, 1986, PHARMACOTHERAPY, V6, P73

[10]

DIMMITT DC, 1988, PHARMACEUT RES, V4, pS82

← 1 2 3 4 5 →